Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

±¹¼Ò ÁøÇ༺ Á÷Àå¾Ï¿¡¼­ ¼ö¼ú Àü Ç×¾Ï È­Çо๰ ¹× ¹æ»ç¼± º´Çà Ä¡·áÀÇ È¿°ú ¹× ¼ö¼ú ÈÄ ÀÌȯÀ²¿¡ ¹ÌÄ¡´Â ¿µÇâ The Effects and Surgical Morbidity of Preoperative Combined Chemoradiotherapy for Locally Advanced Rectal Cancer

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 2001³â 17±Ç 6È£ p.324 ~ 331
Á¤ÁöÀº, ±è°©ÅÂ, Á¤À»»ï,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤ÁöÀº ( Jung Ji-Eun ) 
ÀüÁÖ¿¹¼öº´¿ø ¿Ü°ú

±è°©Å ( Kim Kab-Tae ) 
ÀüÁÖ¿¹¼öº´¿ø ¿Ü°ú
Á¤À»»ï ( Chung Eul-Sam ) 
ÀüÁÖ¿¹¼öº´¿ø ¿Ü°ú

Abstract


Purpose: The aim of this study is to evaluate the effectiveness and surgical morbidity of preoperative chemoradiotherapy for locally advanced rectal cancer.

Methods: Between December 1997 and March 2000, 36 patients with locally advanced rectal cancer (clinical stage II or III) were treated with preoperative chemoradiation: bolus i.v. leucovorin, 20 §·/§³, plus 24-h continuous infusion i.v. 5-Fluorouracil, 425 §·/§³, Days 1¡­5, 29¡­33 and concurrent radiotherapy 4,500 cGy over 5 weeks. Surgery was performed 4¡­8 weeks after completion of the chemoradiotherapy.

Results: Grade 3¡­4 toxicity during chemoradiotherapy was low: hematological toxicities 2.8%, gastro-intestinal toxicities 5.5% and skin toxicities 8.3%. Complete response rate was 16.7% and partial response rate was 47.2%, the rate of downstaging for tumor was 65.5%. The overall rate of resectability was 94.1%. In 13 of 22 (59.1%) patients planned APR, the sphincter was preserved. The overall rate of surgical morbidity was 23.5%, but there was no postoperative mortality. One patient needed a reoperation because a complication may be associated with preoperative chemoradiotherapy.

Conclusions: Preoperative chemoradiotherapy for locally advanced rectal cancer seems to afford some potential advantages: patients are able to tolerate higher chemotherapy doses with low toxicities; tumor downstaging and resectability rates are high; sphincter preservation is feasible; But perioperative morbidity has generally tolerable complications. And so we recommend the preoperative chemoradiotherapy may be one of the best treatments for locally advanced rectal cancer.

Å°¿öµå

Á÷Àå¾Ï;±¹¼Ò ÁøÇ༺;¼ö¼ú Àü È­ÇÐ ¹æ»ç¼± ¿ä¹ý
Rectal cancer;Locally advanced;Preoperative chemoradiotherapy

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS